This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Cancer Care Ontario, Mcgill University. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 570 
Years Active: 2012
Title: Brent W Zanke: Innovator in Colorectal Cancer Risk Assessment
Introduction
Brent W Zanke is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of medical research, particularly in the assessment of colorectal cancer risk. His innovative approach has the potential to impact early detection and prevention strategies.
Latest Patents
Brent W Zanke holds a patent for a method titled "Assessment of risk for colorectal cancer." This patent discloses a method for identifying individuals who have an altered risk for developing colorectal cancer by detecting a single nucleotide polymorphism (SNP). This advancement is crucial for enhancing personalized medicine and improving patient outcomes.
Career Highlights
Throughout his career, Brent has worked with esteemed organizations such as Cancer Care Ontario and McGill University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Brent has collaborated with notable colleagues, including Michelle Cotterchio and Steven Gallinger. Their combined expertise has fostered advancements in cancer research and risk assessment methodologies.
Conclusion
Brent W Zanke's work in colorectal cancer risk assessment exemplifies the importance of innovation in medical research. His contributions are paving the way for improved detection and prevention strategies in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile